Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus
Abstract
Background Intensive insulin treatment effectively delays the onset and slows the progression of microvascular complications in insulin-dependent diabetes mellitus (IDDM). Variable adherence to insulin treatment is thought to contribute to poor glycaemic control, diabetic ketoacidosis, and brittle diabetes in adolescents and young adults with IDDM. We assessed the association between the prescribed insulin dose and the amount dispensed from all community pharmacies with the Diabetes Audit and Research in Tayside Scotland (DARTS) database.Methods We studied 89 patients, mean age 16 (SD 7) years, diabetes duration 8 (4) years, and glycosylated haemoglobin (HbA1c) 8.4 (1.9)%, who attended a teaching hospital paediatric or young-adult diabetes clinic in 1993 and 1994. The medically recommended insulin dose and cumulative volume of insulin prescriptions supplied were used to calculate the days of maximum possible insulin coverage per annum, expressed as the adherence index. Associations between glycaemic control (HbA1c), episodes of diabetic ketoacidosis, and all hospital admissions for acute complications and the adherence index were modelled.Findings Insulin was prescribed at 48 (19) IU/day and mean insulin collected from pharmacies was 58 (25) IU/day, 25 (28%) of the 89 patients obtained less insulin than their prescribed dose (mean deficit 115 (68; range 9-246] insulin days/annum). There was a significant inverse association between HbA1c and the adherence index (R2 = 0.39; p < 0.001). In the top quartile (HbA1c > 10%), 14 (64%) of individuals had an adherence index suggestive of a missed dose of insulin (mean deficit 55 insulin days/annum). There were 36 admissions for complications related to diabetes. The adherence index was inversely related to hospital admissions for diabetic ketoacidosis (p < 0.001) and all hospital admissions related to acute diabetes complications (p = 0.008). The deterioration in glycaemic control observed in patients aged 10-20 years was associated with a significant reduction (p = 0.01) in the adherence index.Interpretation We found direct evidence of poor compliance with insulin therapy in young patients with IDDM. We suggest that poor adherence to insulin treatment is the major factor that contributes to long-term poor glycaemic control and diabetic ketoacidosis in this age group.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
This was the first study to investigate the effects of missed basal insulin injections using accurate injection data from a smart insulin pen.
“The present study was the first to investigate the effects of missed basal insulin injections using accurate injection data from a smart insulin pen; previous studies using data from smart insulin pens have primarily focused on missed bolus insulin doses.4,8”
From Smart Pen Exposes Missed Basal Insulin Injections and Reveals the Impact on Glycemic Control in Adults With Type 1 Diabetes (2024) · cites this paper as [4]
Previous studies using data from smart insulin pens have primarily focused on missed bolus insulin doses.
“The present study was the first to investigate the effects of missed basal insulin injections using accurate injection data from a smart insulin pen; previous studies using data from smart insulin pens have primarily focused on missed bolus insulin doses.4,8”
From Smart Pen Exposes Missed Basal Insulin Injections and Reveals the Impact on Glycemic Control in Adults With Type 1 Diabetes (2024) · cites this paper as [4]
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667 · see citing works
Reichard, P., Nilsson, B.-Y., & Rosenqvist, U. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307293290502 · Cited by 1,202 · see citing works
Rydall, A. C., Rodin, G., Olmsted, M. P., Devenyi, R. G., & Daneman, D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362601 · Cited by 491 · see citing works
Analysis of Covariance Using the Rank Transformation
Conover, W. J., & Iman, R. L. (1982) · Biometrics · doi:10.2307/2530051 · Cited by 448 · see citing works
Schafer, L. C., McCaul, K. D., & Glasgow, R. E. (1986) · Diabetes Care · doi:10.2337/diacare.9.2.179 · Cited by 310 · see citing works
Insulin Omission in Women With IDDM
Polonsky, W. H., Anderson, B. J., Lohrer, P. A., Aponte, J. E., Jacobson, A. M., & Cole, C. F. (1994) · Diabetes Care · doi:10.2337/diacare.17.10.1178 · Cited by 299 · see citing works
Morris, A. D., Boyle, D. I., MacAlpine, R., Emslie-Smith, A. M., Jung, R. T., Newton, R. W., & MacDonald, T. M. (1997) · BMJ · doi:10.1136/bmj.315.7107.524 · Cited by 297 · see citing works
Self-citationThe Relationship Between the Health Belief Model and Compliance of Persons with Diabetes Mellitus
Cerkoney, K. A. B., & Hart, L. K. (1980) · Diabetes Care · doi:10.2337/diacare.3.5.594 · Cited by 259 · see citing works
Adherence in Diabetes: Can We Define It and Can We Measure It?
McNabb, W. (1997) · Diabetes Care · doi:10.2337/diacare.20.2.215 · Cited by 204 · see citing works
Self-care behaviors and glycemic control in type I diabetes
Glasgow, R. E., McCaul, K. D., & Schafer, L. C. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90173-1 · Cited by 176 · see citing works
Lasagna, L. C. (1995) · JAMA · doi:10.1001/jama.1995.03520360084048 · Cited by 168 · see citing works
Adherence to Diabetes Regimens: Empirical Status and Clinical Applications
Kurtz, S. M. (1990) · The Science of Diabetes Self-Management and Care · doi:10.1177/014572179001600112 · Cited by 152 · see citing works
Eating Disorders in Female Adolescents with Insulin Dependent Diabetes Mellitus
Rodin, G., Johnson, L. E., Garfinkel, P. E., Daneman, D., & Kenshole, A. B. (1987) · The International Journal of Psychiatry in Medicine · doi:10.2190/hulh-ctpr-4v17-383c · Cited by 93 · see citing works
Acerini, C. L., Patton, C. M., Savage, M. O., Kernell, A., Westphal, O., & Dunger, D. B. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06467-2 · Cited by 89 · see citing works
Diabetic ketoacidosis. A combined metabolic-nephrologic approach to therapy
DeFronzo, R. A., & Matsuda, M. (1994) · Diabetes reviews · Cited by 70 · see citing works
The Tayside Medicines Monitoring Unit (MEMO)
Wei, L., Parkinson, J., & MacDonald, T. M. (2006) · Pharmacoepidemiology · doi:10.1002/9780470059876.ch21 · Cited by 68 · see citing works
Self-citationPrevalence and characteristics of brittle diabetes in Britain
Gill, G., Lucas, S. S., & Kent, L. (1996) · QJM · doi:10.1093/qjmed/89.11.839 · Cited by 58 · see citing works
Brittle diabetes — present concepts
Gill, G., Walford, S., & Alberti, K. G. M. M. (1985) · Diabetologia · doi:10.1007/bf00281992 · Cited by 49 · see citing works
Abnormal Insulin Treatment Behaviour: a Major Cause of Ketoacidosis in the Young Adult
Thompson, C. J., Cummings, F. J. R., Chalmers, J., et al. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00508.x · Cited by 42 · see citing works
SERIOUS RETINOPATHY IN A DIABETIC CLINIC: PREVALENCE AND THERAPEUTIC IMPLICATIONS
Scobie, I. N., MacCuish, A. C., Barrie, T. S., et al. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90898-9 · Cited by 42 · see citing works
Macfarlane, G. J. (1996) · Journal of Epidemiology & Community Health · doi:10.1136/jech.50.5.602-a · Cited by 40 · see citing works
Leese, G., Newton, R. W., Jung, R. T., et al. (1992) · Diabetic Medicine · doi:10.1111/j.1464-5491.1992.tb01817.x · Cited by 30 · see citing works
Self-citationGill, G., & Alberti, K. G. M. M. (1991) · BMJ · doi:10.1136/bmj.303.6797.285 · Cited by 18 · see citing works
Steel, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92333-7 · Cited by 15 · see citing works
Diabetes and the endocrine changes of puberty
Dunger, D. B., & Edge, J. A. (1995) · Practical Diabetes · doi:10.1002/pdi.1960120205 · Cited by 9 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729 · see citing works
Shippee, N. D., Shah, N. D., May, C. R., Mair, F. S., & Montori, V. M. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.05.005 · Cited by 728 · see citing works
Peyrot, M., Barnett, A. H., Meneghini, L. F., & Schumm‐Draeger, P. ‐. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03605.x · Cited by 655 · see citing works
Peters, A., Laffel, L., & the American Diabetes Association Transitions Working Group (2011) · Diabetes Care · doi:10.2337/dc11-1723 · Cited by 581 · see citing works
Schmitt, A., Gahr, A., Hermanns, N., Kulzer, B., Huber, J., & Haak, T. (2013) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-11-138 · Cited by 587 · see citing works
A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic Outcomes
Asche, C., LaFleur, J., & Conner, C. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.01.019 · Cited by 420 · see citing works
Correlates of Insulin Injection Omission
Peyrot, M., Rubin, R. R., Kruger, D. F., & Travis, L. B. (2010) · Diabetes Care · doi:10.2337/dc09-1348 · Cited by 407 · see citing works
Bergenstal, R. M., Ahmann, A. J., Bailey, T., Beck, R. W., Bissen, J., Buckingham, B., Deeb, L., Dolin, R. H., Garg, S. K., Goland, R., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0051 · Cited by 307 · see citing works
Evans, J. M. M., Newton, R. W., Ruta, D. A., MacDonald, T. M., Stevenson, R. J., & Morris, A. D. (1999) · BMJ · doi:10.1136/bmj.319.7202.83 · Cited by 283 · see citing works
Self-citationHyperglycemic crises in adults with diabetes: a consensus report
Umpierrez, G. E., Davis, G. M., ElSayed, N. A., Fadini, G. P., Galindo, R. J., Hirsch, I. B., Klonoff, D. C., McCoy, R. G., Misra, S., Gabbay, R. A., et al. (2024) · Diabetes Care · doi:10.2337/dci24-0032 · Cited by 278 · see citing works
Griva, K., Myers, L. B., & Newman, S. (2000) · Psychology & Health · doi:10.1080/08870440008405578 · Cited by 235 · see citing works
Meneghini, L., Atkin, S. L., Gough, S. C. L., Raz, I., Blonde, L., Shestakova, M., Bain, S., Johansen, T., Begtrup, K., Birkeland, K. I., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1668 · Cited by 226 · see citing works
Mathieu, C., Hollander, P., Miranda-Palma, B., Cooper, J., Franek, E., Russell-Jones, D., Larsen, J., Tamer, S. C., Bain, S. C., & on behalf of the NN1250-3770 (BEGIN: Flex T1) Trial Investigators (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3249 · Cited by 219 · see citing works
Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes
Cramer, J., Rosenheck, R., Kirk, G., Krol, W., & Krystal, J. (2003) · Value in Health · doi:10.1046/j.1524-4733.2003.65269.x · Cited by 212 · see citing works
Risk of death following admission to a UK hospital with diabetic ketoacidosis
Gibb, F. W., Teoh, W. L., Graham, J., & Lockman, K. A. (2016) · Diabetologia · doi:10.1007/s00125-016-4034-0 · Cited by 170 · see citing works
Medication adherence and glycemic control among newly diagnosed diabetes patients
Lin, L.-K., Sun, Y., Heng, B. H., Chew, D. E. K., & Chong, P.-N. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000429 · Cited by 123 · see citing works
Bode, B. W., McGill, J. B., Lorber, D. L., Gross, J. L., Chang, P.-C., Bregman, D. B., & for the Affinity 1 Study Group (2015) · Diabetes Care · doi:10.2337/dc15-0075 · Cited by 114 · see citing works
Insulin adherence in patients with diabetes: risk factors for injection omission
Farsaei, S., Radfar, M., Heydari, Z., Abbasi, F., & Qorbani, M. (2014) · Primary care diabetes · doi:10.1016/j.pcd.2014.03.001 · Cited by 106 · see citing works
Effect of telephone follow‐up on adherence to a diabetes therapeutic regimen
NESARI, M., ZAKERIMOGHADAM, M., RAJAB, A., BASSAMPOUR, S., & FAGHIHZADEH, S. (2010) · Japan Journal of Nursing Science · doi:10.1111/j.1742-7924.2010.00146.x · Cited by 104 · see citing works
Thalange, N., Deeb, L., Iotova, V., Kawamura, T., Klingensmith, G., Philotheou, A., Silverstein, J., Tumini, S., Ocampo Francisco, A., Kinduryte, O., et al. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12263 · Cited by 91 · see citing works
Chronic conditions in adolescents
Jin, M., An, Q., & Wang, L. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4526 · Cited by 65 · see citing works
Randløv, J., & Poulsen, J. U. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200209 · Cited by 61 · see citing works
Barriers to achieving glycemic targets: who omits insulin and why?
Weinger, K., & Beverly, E. A. (2010) · Diabetes Care · doi:10.2337/dc09-2132 · Cited by 53 · see citing works
Visentin, R., Giegerich, C., Jäger, R., Dahmen, R., Boss, A., Grant, M., Dalla Man, C., Cobelli, C., & Klabunde, T. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0128 · Cited by 36 · see citing works
Ekberg, N. R., Hartvig, N. V., Kaas, A., Møller, J. B., & Adolfsson, P. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221104142 · Cited by 33 · see citing works
Adherence to insulin treatment in diabetes: can it be improved?糖尿病患者使用胰岛素治疗的依从性:它能够得到改善吗?
Doggrell, S. A., & Chan, V. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12212 · Cited by 29 · see citing works
- Authors
- Morris, A. D., Boyle, D. I., McMahon, A. D., Greene, S. A., MacDonald, T. M., & Newton, R. W.
- Affiliations
- University of Dundee (GB)
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1997-11
- Volume
- 350
- Issue
- 9090
- Pages
- 1505-1510
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2117858992
- Cited by
- 507
- References
- 26
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 8 · 2022: 14 · 2021: 15 · 2020: 7 · 2019: 17 · 2018: 19 · 2017: 20 · 2016: 24 · 2015: 21 · 2014: 22 · 2013: 27 · 2012: 30
- FWCI
- 8.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- type 1 diabetes, insulin adherence, glycemic control, HbA1c, diabetic ketoacidosis, hospitalization, adolescents and young adults, community pharmacy dispensing, brittle diabetes, intensive insulin therapy, microvascular complications
- MeSH terms
- Adolescent, Adult, Analysis of Variance, Child, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Hospitalization, Humans, Insulin, Male, Regression Analysis, Scotland, Databases, Factual, Treatment Refusal, Diabetic Ketoacidosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review